TEAMSS (Transforming Expanded Access to Maximize Support and Study) seeks to advance clinical care and translational research by improving patient access to experimental therapies. This federated, national consortium for Expanded Access interventions is a partnership led by the University of Michigan with Duke University, University of Rochester and University of Texas Southwestern

Transforming Expanded Access to Maximize Support and Study

  • Publication

    The Inherent Unfairness of COVID-19 Drug Access Pathways

    American Journal of Bioethics
  • Consortium News
    A picture of Adam Lauring, MD, University of Michigan
    MICHR Enables University of Michigan Physicians to Request Remdesivir Through Expanded Access
  • Publication

    Right now, in the right way: U. S. Food and Drug Administration’s expanded access program and patient rights

    Journal of Clinical and Translational Science